Oncoplastic Surgery Versus Total Breast Reconstruction in Locally Advanced and Multicentric Carcinomas. A Matched Comparative Cohort Study of Oncologic and Aesthetic Outcomes
- 1Federal University of Goias Goiania Brazil
- 2Araujo Jorge Cancer Hospital Goiania Brazil
- 3Albert Einstein Israeli Hospital Goiania Brazil
Abstract
Background/Objective: This study aimed to compare extreme oncoplastic surgery (EO‐partial breast reconstruction for tumors > 5 cm or multicentric lesions) with extreme reconstruction (ER‐mastectomy with reconstruction for tumors >5 cm or multicentric lesions).
Methods: This retrospective cohort study evaluated clinical and pathological parameters, complications, recurrence, survival, and aesthetic outcomes in 276 women, with large or multicentric breast carcinoma who underwent breast reconstruction between March 2004 and September 2025 at a private oncoplastic practice and two tertiary hospitals in Goiânia, Brazil. Data were analyzed using SPSS (version 15.0), with statistical significance set at p < 0.05.
Results: Mean follow‐up was 44 months for EO and 57 months for ER (p = 0.03). Clinical tumor size before chemotherapy was 60 mm in both groups; after neoadjuvant chemotherapy, tumors were smaller in EO (37 mm vs. 44.5 mm, p = 0.02). EO required fewer procedures, with 74% completed in a single surgery, while ER more often required multiple operations (p < 0.01). No significant differences were found between groups regarding margin status or re‐excision rates. In the ER group, 51.40% of patients developed complications, with 18.60% requiring reoperation due to severe events (p < 0.01). Five‐year overall survival was similar (94.40% EO vs. 97.50% ER, p = 0.53), as was locoregional recurrence‐free survival (97%). Patient‐reported outcomes and physician assessments demonstrated superior satisfaction and aesthetic results in EO.
Conclusions: EO provides equivalent oncologic safety to ER, with fewer surgeries, lower complication rates, and improved aesthetic and psychosocial outcomes. These findings support EO as a valid alternative to mastectomy with reconstruction in selected patients with large or multicentric breast cancer.
Related
- Expanding the Boundaries of Breast Conservation: Oncoplastic Surgery in Multifocal and Multicentric Breast Cancer
- Case Report: Synthetic mesh failure and biological mesh salvage in major oncologic abdominal wall reconstruction—a two-case series with technical considerations
- Comparative clinical and molecular profiling of papillary thyroid carcinomas with unilateral and bilateral lateral lymph node metastasis: a retrospective cohort study.
- Pfannenstiel versus periumbilical specimen extraction in laparoscopic low anterior resection: a comparative analysis of incisional hernia risk, postoperative recovery, and oncologic outcomes.
- Active Surveillance in Low- and Intermediate-Risk Prostate Cancer: Comparative Oncologic Safety, Patient Selection, and Predictors of Treatment Conversion in the Era of Multiparametric MRI: A Systematic Review and Meta-Analysis
BibTeX
@article{nunesreis2026oncoplastic,
title = {{Oncoplastic Surgery Versus Total Breast Reconstruction in Locally Advanced and Multicentric Carcinomas. A Matched Comparative Cohort Study of Oncologic and Aesthetic Outcomes}},
author = {Aline Regina Nunes‐Reis and Regis Resende Paulinelli and Rosemar Macedo Sousa Rahal and Luiz Fernando Jubé Ribeiro and Ruffo de Freitas Júnior},
journal = {Journal of Surgical Oncology},
year = {2026},
month = aug,
doi = {10.1002/jso.70372},
url = {https://doi.org/10.1002/jso.70372},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Oncoplastic Surgery Versus Total Breast Reconstruction in Locally Advanced and Multicentric Carcinomas. A Matched Comparative Cohort Study of Oncologic and Aesthetic Outcomes
AU - Aline Regina Nunes‐Reis
AU - Regis Resende Paulinelli
AU - Rosemar Macedo Sousa Rahal
AU - Luiz Fernando Jubé Ribeiro
AU - Ruffo de Freitas Júnior
PY - 2026
DA - 2026/08/17
JO - Journal of Surgical Oncology
DO - 10.1002/jso.70372
UR - https://doi.org/10.1002/jso.70372
AB - Background/Objective: This study aimed to compare extreme oncoplastic surgery (EO‐partial breast reconstruction for tumors > 5 cm or multicentric lesions) with extreme reconstruction (ER‐mastectomy with reconstruction for tumors >5 cm or multicentric lesions). Methods: This retrospective cohort study evaluated clinical and pathological parameters, complications, recurrence, survival, and aesthetic outcomes in 276 women, with large or multicentric breast carcinoma who underwent breast reconstruction between March 2004 and September 2025 at a private oncoplastic practice and two tertiary hospitals in Goiânia, Brazil. Data were analyzed using SPSS (version 15.0), with statistical significance set at p < 0.05. Results: Mean follow‐up was 44 months for EO and 57 months for ER (p = 0.03). Clinical tumor size before chemotherapy was 60 mm in both groups; after neoadjuvant chemotherapy, tumors were smaller in EO (37 mm vs. 44.5 mm, p = 0.02). EO required fewer procedures, with 74% completed in a single surgery, while ER more often required multiple operations (p < 0.01). No significant differences were found between groups regarding margin status or re‐excision rates. In the ER group, 51.40% of patients developed complications, with 18.60% requiring reoperation due to severe events (p < 0.01). Five‐year overall survival was similar (94.40% EO vs. 97.50% ER, p = 0.53), as was locoregional recurrence‐free survival (97%). Patient‐reported outcomes and physician assessments demonstrated superior satisfaction and aesthetic results in EO. Conclusions: EO provides equivalent oncologic safety to ER, with fewer surgeries, lower complication rates, and improved aesthetic and psychosocial outcomes. These findings support EO as a valid alternative to mastectomy with reconstruction in selected patients with large or multicentric breast cancer.
SN - 0022-4790
SN - 1096-9098
ER -